Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease that remains incurable, despite decades of basic and clinical research. Key stakeholders—including the US National ...

Delve into the increasingly dynamic landscape of ALS treatment development with thirteen companies advancing candidates in 2025.

This is the latest venture for Amylyx into the ALS field after its previous therapy Relyvrio was pulled from the market in ...

CAMBRIDGE, Mass. - Amylyx Pharmaceuticals Inc. (NASDAQ: AMLX), a $245.1 million market cap biopharmaceutical company, announced that the U.S. Food and Drug Administration (FDA) has lifted the clinical ...

Steve Gleason and his family were seen having fun in the snow outside their home. His wife and kids were seen on the Lakefront, buddled up and playing in thick snow. Gleason played for the Saints for ...

After raising questions surrounding dosing levels, the FDA has freed Amylyx’s early-stage amyotrophic lateral sclerosis (ALS) ...

The US Food and Drug Administration (FDA) has granted approval for Zydus Lifesciences to proceed with a randomised Phase IIb ...

Ahmedabad: Zydus, a discovery-based, global pharmaceutical company has announced that it has received approval from USFDA to ...

A New Bedford man was sentenced to prison in federal court on Friday for stealing over $450,000 in disability benefits that ...

Former civil servant and avid photographer Yeo Whee Jim, who is no longer able to take photos due to neurological disorder ...

There are 39 total family members consisting of three generations of confirmed cases of ALS. CHARLOTTE, N.C. — Dozens of ...

Plus, Project Healthy Minds, the Trevor Project, and the University of Montana received big gifts to support mental health services, advocacy, and youth in crisis.